Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Viibryd (vilazodone) and fluoxetine (Prozac) are both medications used to treat depression, but they have some key differences. Viibryd is a selective serotonin reuptake inhibitor (SSRI) and a serotonin (5HT1A) receptor partial agonist, while fluoxetine is solely an SSRI. This means that Viibryd not only increases serotonin levels but also directly acts on serotonin receptors. Fluoxetine is used to treat a wider range of conditions in adults and some children, such as obsessive-compulsive disorder (OCD), bulimia, panic disorder, and depression from bipolar 1 disorder, whereas Viibryd is only approved for depression in adults. Viibryd is typically taken once daily with food, while fluoxetine can be taken once daily or once weekly, depending on the form. Both medications are available in both brand and generic forms. Common side effects of Viibryd include diarrhea, nausea, and headache, whereas fluoxetine can cause difficulty sleeping, headaches, and tiredness. Both medications can cause withdrawal symptoms if stopped suddenly and have a risk of suicidal thoughts, especially in younger individuals.
Vilazodone (Viibryd)
Fluoxetine (Prozac)
Vilazodone (Viibryd)
Fluoxetine (Prozac)
Summary of Viibryd vs. Prozac
Summary for SSRI / 5HT1A receptor partial agonist
Prescription only
Vilazodone (Viibryd) is a medication that treats depression in adults. It's taken by mouth, typically just once daily. As with most antidepressants, you should never stop this medication all of a sudden because doing so can lead to withdrawal symptoms. Some of the more common side effects of vilazodone (Viibryd) include diarrhea, nausea, and headache. Research suggests it's less likely to cause weight gain and sexual side effects compared to some other antidepressants. Vilazodone (Viibryd) is available as both brand and generics.